<?xml version='1.0' encoding='UTF-8'?>
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front><journal-meta><journal-id journal-id-type="nlm-ta">Nat Sci Sleep</journal-id><journal-id journal-id-type="iso-abbrev">Nat Sci Sleep</journal-id><journal-id journal-id-type="publisher-id">nss</journal-id><journal-title-group><journal-title>Nature and Science of Sleep</journal-title></journal-title-group><issn pub-type="epub">1179-1608</issn><publisher><publisher-name>Dove</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38737461</article-id><article-id pub-id-type="pmc">11086425</article-id><article-id pub-id-type="publisher-id">453259</article-id><article-id pub-id-type="doi">10.2147/NSS.S453259</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Characterisation of Symptom and Polysomnographic Profiles Associated with Cardiovascular Risk in a Sleep Clinic Population with Obstructive Sleep Apnoea</article-title><alt-title alt-title-type="running-authors">Kemp et al</alt-title><alt-title alt-title-type="running-title">Kemp et al</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kemp</surname><given-names>Emily</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6106-7303</contrib-id><name><surname>Sutherland</surname><given-names>Kate</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4954-2658</contrib-id><name><surname>Bin</surname><given-names>Yu Sun</given-names></name><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2559-3706</contrib-id><name><surname>Chan</surname><given-names>Andrew S L</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Dissanayake</surname><given-names>Hasthi</given-names></name><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Yee</surname><given-names>Brendon J</given-names></name><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff0004" ref-type="aff">
<sup>4</sup>
</xref><xref rid="aff0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kairaitis</surname><given-names>Kristina</given-names></name><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff0006" ref-type="aff">
<sup>6</sup>
</xref><xref rid="aff0007" ref-type="aff">
<sup>7</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wheatley</surname><given-names>John Robert</given-names></name><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff0006" ref-type="aff">
<sup>6</sup>
</xref><xref rid="aff0007" ref-type="aff">
<sup>7</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>de Chazal</surname><given-names>Philip</given-names></name><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff0008" ref-type="aff">
<sup>8</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Piper</surname><given-names>Amanda J</given-names></name><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Cistulli</surname><given-names>Peter A</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="an0001" ref-type="corresp"/></contrib><contrib contrib-type="author"><collab>On behalf of the Sydney Sleep Biobank Investigators</collab></contrib><aff id="aff0001"><label>1</label><institution>Department of Respiratory Medicine, Royal North Shore Hospital</institution>, <addr-line>St Leonards</addr-line>, <addr-line>NSW</addr-line>, <country>Australia</country></aff><aff id="aff0002"><label>2</label><institution>Charles Perkins Centre, University of Sydney</institution>, <addr-line>Camperdown</addr-line>, <addr-line>NSW</addr-line>, <country>Australia</country></aff><aff id="aff0003"><label>3</label><institution>Faculty of Medicine and Health, University of Sydney</institution>, <addr-line>Camperdown</addr-line>, <addr-line>NSW</addr-line>, <country>Australia</country></aff><aff id="aff0004"><label>4</label><institution>Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital</institution>, <addr-line>Camperdown</addr-line>, <addr-line>NSW</addr-line>, <country>Australia</country></aff><aff id="aff0005"><label>5</label><institution>Centre for Integrated Research and Understanding of Sleep (CIRUS), Woolcock Institute of Medical Research</institution>, <addr-line>Glebe</addr-line>, <addr-line>NSW</addr-line>, <country>Australia</country></aff><aff id="aff0006"><label>6</label><institution>Ludwig Engel Centre for Respiratory Research, Westmead Institute for Medical Research</institution>, <addr-line>Westmead</addr-line>, <addr-line>NSW</addr-line>, <country>Australia</country></aff><aff id="aff0007"><label>7</label><institution>Department of Respiratory and Sleep Medicine, Westmead Hospital</institution>, <addr-line>Westmead</addr-line>, <addr-line>NSW</addr-line>, <country>Australia</country></aff><aff id="aff0008"><label>8</label><institution>School of Biomedical Engineering, The University of Sydney</institution>, <addr-line>Darlington</addr-line>, <addr-line>NSW</addr-line>, <country>Australia</country></aff></contrib-group><author-notes><corresp id="an0001">Correspondence: Peter A Cistulli, Department of Respiratory and Sleep Medicine, Level 8A, Royal North Shore Hospital, <addr-line>St Leonards</addr-line>, <addr-line>NSW</addr-line>, <addr-line>2065</addr-line>, <country>Australia</country>, <phone content-type="general">Tel +61 29463 2934</phone>, <fax>Fax +61 2 9463 2099</fax>, Email peter.cistulli@sydney.edu.au</corresp></author-notes><pub-date pub-type="epub"><day>06</day><month>5</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>16</volume><fpage>461</fpage><lpage>471</lpage><history><date date-type="received"><day>31</day><month>12</month><year>2023</year></date><date date-type="accepted"><day>27</day><month>4</month><year>2024</year></date></history><permissions><copyright-statement>© 2024 Kemp et al.</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Kemp et al.</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/3.0/</ali:license_ref><license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p></license></permissions><abstract><sec id="s2001"><title>Aim</title><p><citation_analysis attribute="neither">Recent data have identified specific symptom and polysomnographic profiles associated with cardiovascular disease (CVD) in patients with obstructive sleep apnoea (OSA). Our aim was to determine whether these profiles were present at diagnosis of OSA in patients with established CVD and in those with high cardiovascular risk. Participants in the Sydney Sleep Biobank (SSB) database, aged 30–74 years, self-reported presence of CVD (coronary artery disease, cerebrovascular disease, or heart failure). In those without established CVD, the Framingham Risk Score (FRS) estimated 10-year absolute CVD risk, categorised as “low” (&lt;6%), “intermediate” (6–20%), or “high” (&gt;20%). Groups were compared on symptom and polysomnographic variables.</citation_analysis></p></sec><sec id="s2002"><title>Results</title><p><citation_analysis attribute="neither">629 patients (68% male; mean age 54.3 years, SD 11.6; mean BMI 32.3 kg/m</citation_analysis><citation_analysis attribute="positive"><sup>2</sup></citation_analysis><citation_analysis attribute="positive">, SD 8.2) were included. CVD was reported in 12.2%. A further 14.3% had a low risk FRS, 38.8% had an intermediate risk FRS, and 34.7% had a high risk FRS. Groups differed with respect to age, sex and BMI. OSA severity increased with established CVD and increasing FRS. The symptom of waking too early was more prevalent in the higher FRS groups (p=0.004). CVD and FRS groups differed on multiple polysomnographic variables; however, none of these differences remained significant after adjusting for age, sex, and BMI.</citation_analysis></p></sec><sec id="s2003"><title>Conclusion</title><p><citation_analysis attribute="positive">Higher CVD risk was associated with waking too early in patients with OSA. Polysomnographic variations between groups were explained by demographic differences. Further work is required to explore the influence of OSA phenotypic characteristics on susceptibility to CVD.</citation_analysis></p></sec></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>obstructive sleep apnoea</kwd><kwd>cardiovascular disease</kwd></kwd-group><funding-group><award-group><funding-source>
<institution-wrap><institution>not receive any specific grant from funding</institution></institution-wrap>
</funding-source></award-group><funding-statement>This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</funding-statement></funding-group><counts><fig-count count="0"/><table-count count="11"/><ref-count count="44"/><page-count count="11"/></counts></article-meta></front>
  <body>
    <sec sec-type="intro" id="s0001">
      <title>Introduction</title>
      <p><citation_analysis attribute="neither">Obstructive Sleep Apnoea (OSA) is a highly prevalent sleep disorder estimated to affect nearly one billion people globally.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0001" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="neither"> Repetitive collapse of the pharyngeal airway promotes sympathetic activation, oxidative stress, inflammation, and mechanical strain on the heart, which mechanistically links OSA to the development of cardiovascular disease (CVD).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0002" ref-type="bibr">2</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">In recent years, there has been increasing recognition of OSA as a heterogenous disorder.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0004" ref-type="bibr">4</xref></citation_analysis><citation_analysis attribute="neither"> Specific phenotypes have been identified,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0004" ref-type="bibr">4–6</xref></citation_analysis><citation_analysis attribute="neither"> some of which have links to CVD. For example, an excessively sleepy symptom subtype has been linked to the development of CVD.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0007" ref-type="bibr">7</xref></citation_analysis><citation_analysis attribute="neither"> Similarly, polysomnographic variables such as hypoxia,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0008" ref-type="bibr">8</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0009" ref-type="bibr">9</xref></citation_analysis><citation_analysis attribute="neither"> breathing disturbance during rapid eye movement (REM) sleep</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0010" ref-type="bibr">10</xref></citation_analysis><citation_analysis attribute="neither"> and presence of periodic limb movements</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0008" ref-type="bibr">8</xref></citation_analysis><citation_analysis attribute="neither"> may also predict cardiovascular outcomes over and above the apnoea hypopnoea index (AHI).</citation_analysis></p>
      <p><citation_analysis attribute="positive">It is unknown whether these same phenotypes are evident at diagnosis of OSA in both those with established CVD and in individuals without CVD but with elevated CVD risk, as assessed by Framingham Risk Score.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0011" ref-type="bibr">11</xref></citation_analysis><citation_analysis attribute="positive"> Our aims were firstly to characterise symptom and polysomnographic profiles that were associated with established CVD at diagnosis of OSA. Secondly, we aimed to see whether these same patterns were evident in those without CVD but with elevated CVD risk. We hypothesised that those with established CVD, and those with high CVD risk, would be more likely to be excessively sleepy, and display polysomnographic features such as hypoxia and more breathing disturbances in REM sleep.</citation_analysis></p>
    </sec>
    <sec id="s0002">
      <title>Methods</title>
      <sec id="s0002-s2001">
        <title>Participants</title>
        <p><citation_analysis attribute="neither">The Sydney Sleep Biobank (SSB)</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0012" ref-type="bibr">12</xref></citation_analysis><citation_analysis attribute="positive"> prospectively recruits participants at three tertiary hospital sleep laboratories in Sydney, Australia (Royal North Shore Hospital, Royal Prince Alfred Hospital, Westmead Hospital). Participants were eligible for recruitment if they were aged over 18 years, could give informed consent, and were attending for overnight polysomnography at one of the three sites. The SSB protocol complies with the declaration of Helsinki and has been approved by the Northern Sydney Local Health District (NSLHD) Human Research Ethics Committee (HREC) protocol number HREC/17/HAWKE/340, with site specific approval at all sites (Royal North Shore Hospital no. SSA/18/HAWKE/127, Westmead no. SSA/18/WMEAD/163, Royal Prince Alfred no. SSA/18/RPAH/470). SSB data collection occurred on the night preceding and morning after polysomnography and included demographic information, anthropometric data, detailed questionnaire data and biological samples. Participants did not have a pre-existing diagnosis of OSA. Data from participants in the SSB database as of 26 April 2022 who were aged 30–74, completed the required information for this analysis, and whose polysomnogram was diagnostic of OSA (AHI ≥ 5) were included.</citation_analysis></p>
      </sec>
      <sec id="s0002-s2002">
        <title>Cardiovascular Disease</title>
        <p><citation_analysis attribute="neither">Participants were classified as having established CVD if they self-reported having ever been diagnosed with: 1) coronary artery disease (eg angina, myocardial infarction, heart attack, coronary artery stent, coronary artery bypass surgery); 2) cerebrovascular disease (eg stroke or transient ischaemic attack [TIA]); or 3) heart failure, in the medical history component of the SSB questionnaire. Otherwise, they were classified as not having CVD.</citation_analysis></p>
      </sec>
      <sec id="s0002-s2003">
        <title>Cardiovascular Risk Assessment</title>
        <p><citation_analysis attribute="positive">In those without established CVD, the Framingham Risk Score (FRS) for 10-year general CVD risk was calculated using the office-based, non-laboratory version (body mass index [BMI], instead of total and HDL Cholesterol) of the prediction model.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0011" ref-type="bibr">11</xref></citation_analysis><citation_analysis attribute="positive"> Participants were restricted to ages 30–74 years, as the model is only validated for these age groups. Variables used to calculate FRS risk included: sex, age, systolic blood pressure (BP), BMI, use of anti-hypertensive medication, cigarette smoking, and history of diabetes; and was performed using a freely available Microsoft Excel spreadsheet calculator (</citation_analysis><citation_analysis attribute="positive"><underline><ext-link xlink:href="https://framinghamheartstudy" ext-link-type="uri">https://framinghamheartstudy</ext-link></underline></citation_analysis><citation_analysis attribute="negative">.org/fhs-risk-functions/cardiovascular-disease-10-year-risk/). Systolic BP measurement was obtained in the evening prior to polysomnography and on the following morning by a trained research assistant for resting, seated office BP measurement. The higher of the two values was used to calculate the FRS risk. Height and weight were also measured in the evening. The other risk predictor variables were obtained from the SSB medical history questionnaire completed by the participant. A ten-year risk score designated as low (&lt;6%), intermediate (6–20%) or high (≥20%) risk for general CVD was obtained from the equation.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0011" ref-type="bibr">11</xref></citation_analysis></p>
      </sec>
      <sec id="s0002-s2004">
        <title>Sleep Symptoms and Quality</title>
        <p><citation_analysis attribute="positive">Comprehensive symptom data were collected using standard validated questionnaires, including the Epworth Sleepiness Scale (ESS),</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0013" ref-type="bibr">13</xref></citation_analysis><citation_analysis attribute="neither"> Functional Outcomes of Sleep Questionnaire short form (FOSQ-10),</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0014" ref-type="bibr">14</xref></citation_analysis><citation_analysis attribute="neither"> Pittsburgh Sleep Quality Index (PSQI),</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0015" ref-type="bibr">15</xref></citation_analysis><citation_analysis attribute="neither"> SAGIC Sleep Questionnaire,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0016" ref-type="bibr">16</xref></citation_analysis><citation_analysis attribute="neither"> Insomnia Severity Questionnaire (ISQ),</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0017" ref-type="bibr">17</xref></citation_analysis><citation_analysis attribute="neither"> and the Berlin Sleep Questionnaire.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0018" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="neither"> Total scores for the ESS, FOSQ-10 and PSQI were calculated. Additionally, twelve symptom variables (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0001" ref-type="table">Table 1</xref></citation_analysis><citation_analysis attribute="neither">) were chosen from these questionnaires to align with previously published work investigating symptom phenotypes in OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0019" ref-type="bibr">19</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0020" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="neither"> Participant responses were dichotomised into “present” if they occurred at least once per week, or “absent” if they occurred less frequently or did not occur at all. Results for total scores and dichotomised variables were compared between cardiovascular groups.</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0001"><label>Table 1</label><caption><p><citation_analysis attribute="neither">Symptom Variables Included for Analysis</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Domain</th><th rowspan="1" colspan="1">Symptom</th></tr></thead><tbody><tr><td rowspan="5" colspan="1">Sleepiness</td><td rowspan="1" colspan="1">How often do you feel tired or fatigued after your sleep?</td></tr><tr><td rowspan="1" colspan="1">I feel very sleepy during the day</td></tr><tr><td rowspan="1" colspan="1">During your waking time, do you feel tired, fatigued, or not up to par?</td></tr><tr><td rowspan="1" colspan="1">I fall asleep involuntarily during the day</td></tr><tr><td rowspan="1" colspan="1">I often take naps or doze off</td></tr><tr><td rowspan="3" colspan="1">Insomnia</td><td rowspan="1" colspan="1">During the past month, how often have you had difficulty staying asleep?</td></tr><tr><td rowspan="1" colspan="1">During the past month, how often have you had difficulty falling asleep?</td></tr><tr><td rowspan="1" colspan="1">During the past month, how often have you had trouble waking up too early in the morning and being unable to fall back asleep?</td></tr><tr><td rowspan="3" colspan="1">Disturbed sleep</td><td rowspan="1" colspan="1">I toss, turn and thrash excessively during the night</td></tr><tr><td rowspan="1" colspan="1">I sweat/perspire excessively during the night</td></tr><tr><td rowspan="1" colspan="1">I wake up suddenly and feel as if I cannot breathe</td></tr><tr><td rowspan="1" colspan="1">Upper airway symptoms</td><td rowspan="1" colspan="1">Do you snore?</td></tr></tbody></table></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
      </sec>
      <sec id="s0002-s2005">
        <title>Polysomnography</title>
        <p><citation_analysis attribute="positive">All polysomnography was scored using standard criteria (AASM Manual V2.6,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0021" ref-type="bibr">21</xref></citation_analysis><citation_analysis attribute="neither"> with minor clarifications recommended for standardisation across Australasian sleep services).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0022" ref-type="bibr">22</xref></citation_analysis><citation_analysis attribute="positive"> Polysomnographic variables in the domains of sleep architecture (sleep stages, sleep latency and efficiency), breathing disturbance (respiratory events in NREM and REM, apnoeas versus hypopnoeas), hypoxaemia (oxygen saturation, time spent below 90% oxygen saturation, oxygen desaturation index) and other (cortical arousals and periodic limb movements [PLMs]) were assessed and compared between cardiovascular groups.</citation_analysis></p>
      </sec>
      <sec id="s0002-s2006">
        <title>Statistical Analysis</title>
        <p><citation_analysis attribute="positive">Statistical analysis was performed using Jamovi v2.3.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0023" ref-type="bibr">23</xref></citation_analysis><citation_analysis attribute="positive"> Data are presented as mean (standard deviation) or N (%). Continuous variables were assessed for normality of distribution using the Shapiro–Wilk test and for the most part were found to have a non-parametric distribution. Polysomnographic and symptom variables were compared between those with and without established cardiovascular disease using the Mann–Whitney </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">U</italic></citation_analysis><citation_analysis attribute="positive">-test for continuous variables and Chi Squared test of independence for categorical variables. In those without established cardiovascular disease, polysomnographic and symptom variables were compared across FRS groups using the Independent Samples Kruskal–Wallis test for continuous data and Chi Squared tests for categorical data. Polysomnographic variables were additionally assessed using ANCOVA to adjust for age, sex and BMI. As this was an exploratory study, no adjustment for multiple comparisons was made. Statistical significance was accepted at p&lt;0.05.</citation_analysis></p>
      </sec>
    </sec>
    <sec id="s0003">
      <title>Results</title>
      <sec id="s0003-s2001">
        <title>Participant Characteristics</title>
        <p><citation_analysis attribute="neither">Of the 1062 participants recruited to the SSB at the time of analysis, 629 participants were aged between 30–74 years, had an apnoea hypopnoea index (AHI)≥ 5, and had completed the required questions for assessing cardiovascular risk. The cohort contained more males (67.7%), and the most common ethnicities were Caucasian (64.0%) and South-East Asian (9.4%). The mean age was 54.3 years (SD 11.6) and the mean BMI was 32.3 kg/m</citation_analysis><citation_analysis attribute="positive"><sup>2</sup></citation_analysis><citation_analysis attribute="positive"> (SD 8.2). Forty four percent of the cohort had ever been smokers. Two hundred and forty-seven participants (39.4%) reported a diagnosis of hypertension; 238 participants (38%) reported dyslipidaemia; 98 participants (15.6%) reported presence of diabetes and 37 participants (5.9%) reported chronic lung disease.</citation_analysis></p>
      </sec>
      <sec id="s0003-s2002">
        <title>Prevalence of Established Cardiovascular Disease and Cardiovascular Disease Risk</title>
        <p><citation_analysis attribute="positive">Seventy seven participants (12.2%) reported established CVD, which was comprised of coronary artery disease (n=48, 7.7%), cerebrovascular disease (n=23, 3.7%), and heart failure (n=25, 4.0%). Those with established CVD were older (mean age 61 years) and had a higher BMI (mean 34.7 kg/m2) than those without CVD (53 years and 32.0 kg/m2, respectively). There was no sex difference between those with and without established CVD.</citation_analysis></p>
        <p><citation_analysis attribute="negative">In those without established CVD (n=552), 90 participants (14.3%) had a Framingham risk score (FRS) less than 6% (“low Risk”); 244 participants (38.8%) had an FRS between 6% and 20% (“intermediate Risk”); and 218 participants (34.7%) had an FRS over 20% (“high Risk”). Low, intermediate, and high CVD risk groups differed with respect to age (40.3 years vs 51.2 years vs 61.1 years, respectively, p&lt;0.001), sex (51% male vs 61% male vs 82% male, p&lt;0.001), and BMI (29.1 kg/m2 vs 31.9 kg/m2 vs 33.2 kg/m2, p&lt;0.001). The prevalence of smoking, hypertension and diabetes across groups is presented in </citation_analysis><citation_analysis attribute="positive"><xref rid="t0002" ref-type="table">Table 2</xref></citation_analysis><citation_analysis attribute="neither">.</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0002"><label>Table 2</label><caption><p><citation_analysis attribute="neither">Prevalence of Smoking, Hypertension and Diabetes Across Groups</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">Total Sample</th><th rowspan="1" colspan="1">Low Risk FRS</th><th rowspan="1" colspan="1">Intermediate Risk FRS</th><th rowspan="1" colspan="1">High Risk FRS</th><th rowspan="1" colspan="1">Established CVD</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age (years)</td><td rowspan="1" colspan="1">54.3 (11.6)</td><td rowspan="1" colspan="1">40.3 (8.2)</td><td rowspan="1" colspan="1">51.2 (9.8)</td><td rowspan="1" colspan="1">61.1 (8.2)</td><td rowspan="1" colspan="1">61.2 (10.0)</td></tr><tr><td rowspan="1" colspan="1">Male sex</td><td rowspan="1" colspan="1">426 (67.7%)</td><td rowspan="1" colspan="1">46 (51.1%)</td><td rowspan="1" colspan="1">148 (60.7%)</td><td rowspan="1" colspan="1">178 (81.7%)</td><td rowspan="1" colspan="1">54 (70.1%)</td></tr><tr><td rowspan="1" colspan="1">BMI (kg/m2)</td><td rowspan="1" colspan="1">32.3 (8.2)</td><td rowspan="1" colspan="1">29.1 (7.4)</td><td rowspan="1" colspan="1">31.9 (8.2)</td><td rowspan="1" colspan="1">33.2 (7.9)</td><td rowspan="1" colspan="1">34.7 (8.7)</td></tr><tr><td rowspan="1" colspan="1">Ever smoked</td><td rowspan="1" colspan="1">277/629 (44%)</td><td rowspan="1" colspan="1">16/90 (17.8%)</td><td rowspan="1" colspan="1">86/244 (35.2%)</td><td rowspan="1" colspan="1">130/218 (59.6%)</td><td rowspan="1" colspan="1">45/77 (58.4%)</td></tr><tr><td rowspan="1" colspan="1">Hypertension</td><td rowspan="1" colspan="1">247/609 (40.6%)</td><td rowspan="1" colspan="1">6/87 (6.9%)</td><td rowspan="1" colspan="1">66/236 (28.0%)</td><td rowspan="1" colspan="1">127/209 (60.8%)</td><td rowspan="1" colspan="1">48/77 (62.3%)</td></tr><tr><td rowspan="1" colspan="1">Diabetes</td><td rowspan="1" colspan="1">98/621 (15.8%)</td><td rowspan="1" colspan="1">1/89 (1.1%)</td><td rowspan="1" colspan="1">14/239 (5.9%)</td><td rowspan="1" colspan="1">59/216 (27.3%)</td><td rowspan="1" colspan="1">24/77 (31.2%)</td></tr></tbody></table><table-wrap-foot><fn id="tfn0001"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="neither">: Data are presented as N(%), except for age and BMI, which are presented as mean(SD).</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
      </sec>
      <sec id="s0003-s2003">
        <title>Sleep Symptoms</title>
        <sec id="s0003-s2003-s3001">
          <title>Established Cardiovascular Disease</title>
          <p><citation_analysis attribute="positive">Presence of established CVD was not associated with significant differences in any measured symptom variable including total scores on sleep questionnaires (ESS, FOSQ-10 and PSQI) (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0003" ref-type="table">Table 3</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0003"><label>Table 3</label><caption><p><citation_analysis attribute="neither">Symptom Variables: Established CVD Vs No CVD</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">Established CVD</th><th rowspan="1" colspan="1">No CVD</th><th rowspan="1" colspan="1">P</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">How often do you feel tired or fatigued after your sleep?</td><td rowspan="1" colspan="1">52 (70.3%)</td><td rowspan="1" colspan="1">410 (76.4%)</td><td rowspan="1" colspan="1">0.254</td></tr><tr><td rowspan="1" colspan="1">I feel very sleepy during the day</td><td rowspan="1" colspan="1">43 (58.1%)</td><td rowspan="1" colspan="1">327 (61.1%)</td><td rowspan="1" colspan="1">0.619</td></tr><tr><td rowspan="1" colspan="1">During your waking time, do you feel tired, fatigued, or not up to par?</td><td rowspan="1" colspan="1">54 (72.0%)</td><td rowspan="1" colspan="1">422 (78.1%)</td><td rowspan="1" colspan="1">0.233</td></tr><tr><td rowspan="1" colspan="1">I fall asleep involuntarily during the day</td><td rowspan="1" colspan="1">23 (31.5%)</td><td rowspan="1" colspan="1">142 (26.7%)</td><td rowspan="1" colspan="1">0.386</td></tr><tr><td rowspan="1" colspan="1">I often take naps or doze off</td><td rowspan="1" colspan="1">38 (52.1%)</td><td rowspan="1" colspan="1">239 (44.7%)</td><td rowspan="1" colspan="1">0.235</td></tr><tr><td rowspan="1" colspan="1">During the past month, how often have you had difficulty staying asleep?</td><td rowspan="1" colspan="1">37 (50.7%)</td><td rowspan="1" colspan="1">252 (47.4%)</td><td rowspan="1" colspan="1">0.595</td></tr><tr><td rowspan="1" colspan="1">During the past month, how often have you had difficulty falling asleep?</td><td rowspan="1" colspan="1">31 (41.9%)</td><td rowspan="1" colspan="1">191 (35.7%)</td><td rowspan="1" colspan="1">0.300</td></tr><tr><td rowspan="1" colspan="1">During the past month, how often have you had trouble waking up too early in the morning and being unable to fall back asleep?</td><td rowspan="1" colspan="1">36 (48.6%)</td><td rowspan="1" colspan="1">243 (45.8%)</td><td rowspan="1" colspan="1">0.641</td></tr><tr><td rowspan="1" colspan="1">I toss, turn and thrash excessively during the night</td><td rowspan="1" colspan="1">31 (43.1%)</td><td rowspan="1" colspan="1">251 (46.6%)</td><td rowspan="1" colspan="1">0.574</td></tr><tr><td rowspan="1" colspan="1">I sweat/perspire excessively during the night</td><td rowspan="1" colspan="1">15 (20.8%)</td><td rowspan="1" colspan="1">111 (20.8%)</td><td rowspan="1" colspan="1">0.999</td></tr><tr><td rowspan="1" colspan="1">I wake up suddenly and feel as if I cannot breathe</td><td rowspan="1" colspan="1">10 (13.7%)</td><td rowspan="1" colspan="1">99 (18.5%)</td><td rowspan="1" colspan="1">0.318</td></tr><tr><td rowspan="1" colspan="1">Do you snore?</td><td rowspan="1" colspan="1">55 (73.3%)</td><td rowspan="1" colspan="1">448 (82.7%)</td><td rowspan="1" colspan="1">0.082</td></tr><tr><td rowspan="1" colspan="1">Epworth Sleepiness Score</td><td rowspan="1" colspan="1">7.9 (5.0)</td><td rowspan="1" colspan="1">7.5 (4.7)</td><td rowspan="1" colspan="1">0.589</td></tr><tr><td rowspan="1" colspan="1">Functional Outcomes of Sleep Questionnaire-10 Score</td><td rowspan="1" colspan="1">29.7 (8.7)</td><td rowspan="1" colspan="1">29.6 (8.8)</td><td rowspan="1" colspan="1">0.933</td></tr><tr><td rowspan="1" colspan="1">Pittsburgh Sleep Quality Index Score</td><td rowspan="1" colspan="1">8.6 (5.2)</td><td rowspan="1" colspan="1">8.6 (5.5)</td><td rowspan="1" colspan="1">0.878</td></tr></tbody></table><table-wrap-foot><fn id="tfn0002"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="neither">: Data are presented as n(%) of participants who responded positively to the symptom occurring at least once per week. Scores are presented as mean(SD).</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
        </sec>
      </sec>
      <sec id="s0003-s2004">
        <title>Cardiovascular Risk Groups</title>
        <p><citation_analysis attribute="positive">Intermediate and high cardiovascular risk groups were associated with waking too early (p=0.004); however, there were no other differences for symptom variables and no significant difference for total ESS, FOSQ-10 or PSQI scores (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0004" ref-type="table">Table 4</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0004"><label>Table 4</label><caption><p><citation_analysis attribute="neither">Symptom Variables: CVD Risk Groups</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">Low Risk</th><th rowspan="1" colspan="1">Intermediate Risk</th><th rowspan="1" colspan="1">High Risk</th><th rowspan="1" colspan="1">P</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">How often do you feel tired or fatigued after your sleep?</td><td rowspan="1" colspan="1">68 (76.4%)</td><td rowspan="1" colspan="1">182 (77.8%)</td><td rowspan="1" colspan="1">160 (74.8%)</td><td rowspan="1" colspan="1">0.755</td></tr><tr><td rowspan="1" colspan="1">I feel very sleepy during the day</td><td rowspan="1" colspan="1">55 (62.8%)</td><td rowspan="1" colspan="1">148 (63.2%)</td><td rowspan="1" colspan="1">124 (58.5%)</td><td rowspan="1" colspan="1">0.583</td></tr><tr><td rowspan="1" colspan="1">During your waking time, do you feel tired, fatigued, or not up to par?</td><td rowspan="1" colspan="1">68 (76.4%)</td><td rowspan="1" colspan="1">188 (80.0%)</td><td rowspan="1" colspan="1">166 (76.9%)</td><td rowspan="1" colspan="1">0.656</td></tr><tr><td rowspan="1" colspan="1">I fall asleep involuntarily during the day</td><td rowspan="1" colspan="1">19 (21.3%)</td><td rowspan="1" colspan="1">62 (27.0%)</td><td rowspan="1" colspan="1">61 (29.0%)</td><td rowspan="1" colspan="1">0.388</td></tr><tr><td rowspan="1" colspan="1">I often take naps or doze off</td><td rowspan="1" colspan="1">37 (41.6%)</td><td rowspan="1" colspan="1">104 (44.3%)</td><td rowspan="1" colspan="1">98 (46.4%)</td><td rowspan="1" colspan="1">0.729</td></tr><tr><td rowspan="1" colspan="1">During the past month, how often have you had difficulty staying asleep?</td><td rowspan="1" colspan="1">32 (36.4%)</td><td rowspan="1" colspan="1">113 (48.7%)</td><td rowspan="1" colspan="1">107 (50.7%)</td><td rowspan="1" colspan="1">0.072</td></tr><tr><td rowspan="1" colspan="1">During the past month, how often have you had difficulty falling asleep?</td><td rowspan="1" colspan="1">34 (38.6%)</td><td rowspan="1" colspan="1">85 (36.2%)</td><td rowspan="1" colspan="1">72 (34.0%)</td><td rowspan="1" colspan="1">0.729</td></tr><tr><td rowspan="1" colspan="1">During the past month, how often have you had trouble waking up too early in the morning and being unable to fall back asleep?</td><td rowspan="1" colspan="1">26 (29.5%)</td><td rowspan="1" colspan="1">113 (48.9%)</td><td rowspan="1" colspan="1">104 (49.1%)</td><td rowspan="1" colspan="1">0.004**</td></tr><tr><td rowspan="1" colspan="1">I toss, turn and thrash excessively during the night</td><td rowspan="1" colspan="1">32 (36.0%)</td><td rowspan="1" colspan="1">115 (49.0%)</td><td rowspan="1" colspan="1">104 (48.4%)</td><td rowspan="1" colspan="1">0.089</td></tr><tr><td rowspan="1" colspan="1">I sweat/perspire excessively during the night</td><td rowspan="1" colspan="1">22 (25.3%)</td><td rowspan="1" colspan="1">41 (17.6%)</td><td rowspan="1" colspan="1">48 (22.5%)</td><td rowspan="1" colspan="1">0.234</td></tr><tr><td rowspan="1" colspan="1">I wake up suddenly and feel as if I cannot breathe</td><td rowspan="1" colspan="1">18 (20.2%)</td><td rowspan="1" colspan="1">43 (18.2%)</td><td rowspan="1" colspan="1">38 (18.0%)</td><td rowspan="1" colspan="1">0.895</td></tr><tr><td rowspan="1" colspan="1">Do you snore?</td><td rowspan="1" colspan="1">76 (85.4%)</td><td rowspan="1" colspan="1">194 (81.9%)</td><td rowspan="1" colspan="1">178 (82.4%)</td><td rowspan="1" colspan="1">0.748</td></tr><tr><td rowspan="1" colspan="1">Epworth Sleepiness Score</td><td rowspan="1" colspan="1">8.3 (5.7)</td><td rowspan="1" colspan="1">7.3 (4.4)</td><td rowspan="1" colspan="1">7.3 (4.7)</td><td rowspan="1" colspan="1">0.548</td></tr><tr><td rowspan="1" colspan="1">Functional Outcomes of Sleep Questionnaire-10 Score</td><td rowspan="1" colspan="1">29.7 (7.9)</td><td rowspan="1" colspan="1">29.3 (8.9)</td><td rowspan="1" colspan="1">29.9 (9.0)</td><td rowspan="1" colspan="1">0.542</td></tr><tr><td rowspan="1" colspan="1">Pittsburgh Sleep Quality Index Score</td><td rowspan="1" colspan="1">8.0 (5.2)</td><td rowspan="1" colspan="1">8.6 (5.7)</td><td rowspan="1" colspan="1">8.8 (5.5)</td><td rowspan="1" colspan="1">0.514</td></tr></tbody></table><table-wrap-foot><fn id="tfn0003"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="neither">: Data are presented as n(%) of participants who responded positively to the symptom occurring at least once per week. Scores are presented as mean(SD) **Significant, p&lt;0.05.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
      </sec>
      <sec id="s0003-s2005">
        <title>Polysomnographic Characteristics</title>
        <sec id="s0003-s2005-s3001">
          <title>Established Cardiovascular Disease</title>
          <p><citation_analysis attribute="positive">Compared to participants without CVD, participants with established CVD had a lower sleep efficiency (p&lt;0.05); lower proportion of REM sleep (p=0.01); higher AHI (p&lt;0.05); higher NREM AHI (p&lt;0.05); lower REM:NREM AHI ratio (p&lt;0.05); higher 3% oxygen desaturation index (ODI3%) (p&lt;0.05); and a higher arousal index (p=0.02). However, none of these differences remained significant after adjusting for age, sex and BMI. All other polysomnographic differences between groups did not remain significant after adjusting for age and sex (see </citation_analysis><citation_analysis attribute="positive"><xref rid="t0005" ref-type="table">Table 5</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0005"><label>Table 5</label><caption><p><citation_analysis attribute="neither">Polysomnographic Variables: Established CVD Vs No CVD</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">Established CVD (n=77)</th><th rowspan="1" colspan="1">No CVD (n=548)</th><th rowspan="1" colspan="1">P (Unadjusted)</th><th rowspan="1" colspan="1">P (Adjusted for Age, Sex, BMI)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Sleep latency (mins)</td><td rowspan="1" colspan="1">18.0 (36.5)</td><td rowspan="1" colspan="1">19.5 (26.5)</td><td rowspan="1" colspan="1">0.640</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">REM latency (mins)</td><td rowspan="1" colspan="1">125.0 (122.5)</td><td rowspan="1" colspan="1">110.5 (91.0)</td><td rowspan="1" colspan="1">0.258</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Sleep efficiency (%)</td><td rowspan="1" colspan="1">72.3 (27.3)</td><td rowspan="1" colspan="1">76.3 (18.3)</td><td rowspan="1" colspan="1">0.013**</td><td rowspan="1" colspan="1">0.196</td></tr><tr><td rowspan="1" colspan="1">Total sleep time (mins)</td><td rowspan="1" colspan="1">336.0 (137.0)</td><td rowspan="1" colspan="1">355.0 (96.8)</td><td rowspan="1" colspan="1">0.062</td><td rowspan="1" colspan="1">0.426</td></tr><tr><td rowspan="1" colspan="1">REM Sleep (%)</td><td rowspan="1" colspan="1">14.0 (10.4)</td><td rowspan="1" colspan="1">16.6 (8.8)</td><td rowspan="1" colspan="1">0.017**</td><td rowspan="1" colspan="1">0.103</td></tr><tr><td rowspan="1" colspan="1">Stage 1 (%)</td><td rowspan="1" colspan="1">11.6 (11.5)</td><td rowspan="1" colspan="1">8.4 (10.0)</td><td rowspan="1" colspan="1">0.119</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Stage 2 (%)</td><td rowspan="1" colspan="1">57.6 (14.3)</td><td rowspan="1" colspan="1">57.1 (15.6)</td><td rowspan="1" colspan="1">0.945</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Stage 3 (%)</td><td rowspan="1" colspan="1">15.0 (19.2)</td><td rowspan="1" colspan="1">14.4 (14.6)</td><td rowspan="1" colspan="1">0.987</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">AHI (events/hr)</td><td rowspan="1" colspan="1">29.4 (33.5)</td><td rowspan="1" colspan="1">20.7 (31.3)</td><td rowspan="1" colspan="1">0.041**</td><td rowspan="1" colspan="1">0.723</td></tr><tr><td rowspan="1" colspan="1">REM AHI (events/hr)</td><td rowspan="1" colspan="1">33.8 (34.9)</td><td rowspan="1" colspan="1">32.2 (41.3)</td><td rowspan="1" colspan="1">0.890</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NREM AHI (events/hr)</td><td rowspan="1" colspan="1">27.4 (36.0)</td><td rowspan="1" colspan="1">18.5 (33.6)</td><td rowspan="1" colspan="1">0.018**</td><td rowspan="1" colspan="1">0.930</td></tr><tr><td rowspan="1" colspan="1">REM:NREM AHI ratio</td><td rowspan="1" colspan="1">1.1 (1.2)</td><td rowspan="1" colspan="1">1.3 (2.2)</td><td rowspan="1" colspan="1">0.027**</td><td rowspan="1" colspan="1">0.254</td></tr><tr><td rowspan="1" colspan="1">Central apnoea index (events/hr)</td><td rowspan="1" colspan="1">0.0 (0.3)</td><td rowspan="1" colspan="1">0.1 (0.6)</td><td rowspan="1" colspan="1">0.202</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">SpO<sub>2</sub> &lt; 90% (mins)</td><td rowspan="1" colspan="1">2.3 (10.9)</td><td rowspan="1" colspan="1">1.4 (7.6)</td><td rowspan="1" colspan="1">0.102</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">ODI (events/hr)</td><td rowspan="1" colspan="1">23.5 (31.3)</td><td rowspan="1" colspan="1">14.4 (26.4)</td><td rowspan="1" colspan="1">0.025**</td><td rowspan="1" colspan="1">0.836</td></tr><tr><td rowspan="1" colspan="1">Awake average SpO<sub>2</sub> (%)</td><td rowspan="1" colspan="1">95.0 (2.0)</td><td rowspan="1" colspan="1">95.0 (2.0)</td><td rowspan="1" colspan="1">0.141</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Lowest SpO<sub>2</sub> (%)</td><td rowspan="1" colspan="1">84.0 (11.0)</td><td rowspan="1" colspan="1">84.0 (10.0)</td><td rowspan="1" colspan="1">0.378</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Arousal index (events/hr)</td><td rowspan="1" colspan="1">33.8 (30.9)</td><td rowspan="1" colspan="1">27.2 (22.9)</td><td rowspan="1" colspan="1">0.050**</td><td rowspan="1" colspan="1">0.358</td></tr><tr><td rowspan="1" colspan="1">PLM index (events/hr)</td><td rowspan="1" colspan="1">0.3 (21.4)</td><td rowspan="1" colspan="1">0.0 (9.3)</td><td rowspan="1" colspan="1">0.062</td><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="tfn0004"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="neither">: Data are presented as median (IQR). **Significant, p&lt;0.05.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
        </sec>
      </sec>
      <sec id="s0003-s2006">
        <title>Cardiovascular Risk Groups</title>
        <p><citation_analysis attribute="positive">There was a clear positive relationship between FRS and OSA severity (median AHI of 13.6/hr (IQR 18.9) in the low risk category; 18.9/hr (IQR 26.4) in the intermediate risk category; 27.6/hr (IQR 26.9) in the high risk category; p&lt;0.001); however, this did not remain significant after adjusting for age, sex, and BMI. Higher CVD risk was also significantly associated with longer sleep latency (p=0.05); lower sleep efficiency (p&lt;0.001); lower total sleep time (p=0.004); higher proportion of total sleep time spent in stage 1 sleep (p=0.006); higher NREM AHI (p&lt;0.001); higher arousal index (p&lt;0.001); higher PLM index (p&lt;0.001); and a greater degree of awake and asleep hypoxia, as assessed by the time spent with oxygen saturation (SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">) below 90% (p&lt;0.001); ODI3% (p&lt;0.001); average awake SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> (p&lt;0.001); and nadir SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="positive"> (p&lt;0.001). However, none of these differences remained significant in the adjusted analyses (see </citation_analysis><citation_analysis attribute="positive"><xref rid="t0006" ref-type="table">Table 6</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0006"><label>Table 6</label><caption><p><citation_analysis attribute="neither">Polysomnographic Variables: CVD Risk Groups</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">Low Risk (n=90)</th><th rowspan="1" colspan="1">Intermediate Risk (n=244)</th><th rowspan="1" colspan="1">High Risk (n=218)</th><th rowspan="1" colspan="1">P (Unadjusted)</th><th rowspan="1" colspan="1">P (Adjusted for Age, Sex, BMI)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Sleep latency (mins)</td><td rowspan="1" colspan="1">15.3 (24.3)</td><td rowspan="1" colspan="1">18.0 (25.1)</td><td rowspan="1" colspan="1">21.5 (28.6)</td><td rowspan="1" colspan="1">0.050**</td><td rowspan="1" colspan="1">0.53</td></tr><tr><td rowspan="1" colspan="1">REM latency (mins)</td><td rowspan="1" colspan="1">109.0 (82.9)</td><td rowspan="1" colspan="1">111.5 (93.1)</td><td rowspan="1" colspan="1">110.5 (88.5)</td><td rowspan="1" colspan="1">0.888</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Sleep efficiency (%)</td><td rowspan="1" colspan="1">80.1 (19.3)</td><td rowspan="1" colspan="1">76.7 (16.9)</td><td rowspan="1" colspan="1">74.3 (17.8)</td><td rowspan="1" colspan="1">&lt;0.001**</td><td rowspan="1" colspan="1">0.18</td></tr><tr><td rowspan="1" colspan="1">Total sleep time (mins)</td><td rowspan="1" colspan="1">370.0 (90.2)</td><td rowspan="1" colspan="1">355.8 (92.3)</td><td rowspan="1" colspan="1">345.0 (103.0)</td><td rowspan="1" colspan="1">0.004**</td><td rowspan="1" colspan="1">0.19</td></tr><tr><td rowspan="1" colspan="1">REM Sleep (%)</td><td rowspan="1" colspan="1">16.7 (8.5)</td><td rowspan="1" colspan="1">16.9 (8.9)</td><td rowspan="1" colspan="1">15.9 (8.4)</td><td rowspan="1" colspan="1">0.653</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Stage 1 (%)</td><td rowspan="1" colspan="1">7.9 (5.9)</td><td rowspan="1" colspan="1">7.7 (9.1)</td><td rowspan="1" colspan="1">9.7 (12.2)</td><td rowspan="1" colspan="1">0.006**</td><td rowspan="1" colspan="1">0.24</td></tr><tr><td rowspan="1" colspan="1">Stage 2 (%)</td><td rowspan="1" colspan="1">57.8 (13.1)</td><td rowspan="1" colspan="1">57.1 (14.4)</td><td rowspan="1" colspan="1">55.9 (17.9)</td><td rowspan="1" colspan="1">0.914</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Stage 3 (%)</td><td rowspan="1" colspan="1">17.2 (12.8)</td><td rowspan="1" colspan="1">14.8 (13.9)</td><td rowspan="1" colspan="1">11.9 (17.6)</td><td rowspan="1" colspan="1">0.003**</td><td rowspan="1" colspan="1">0.72</td></tr><tr><td rowspan="1" colspan="1">AHI (events/hr)</td><td rowspan="1" colspan="1">13.6 (18.8)</td><td rowspan="1" colspan="1">18.9 (26.4)</td><td rowspan="1" colspan="1">27.6 (40.2)</td><td rowspan="1" colspan="1">&lt;0.001**</td><td rowspan="1" colspan="1">0.70</td></tr><tr><td rowspan="1" colspan="1">REM AHI (events/hr)</td><td rowspan="1" colspan="1">27.6 (32.6)</td><td rowspan="1" colspan="1">30.1 (39.4)</td><td rowspan="1" colspan="1">38.6 (41.9)</td><td rowspan="1" colspan="1">0.084</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">NREM AHI (events/hr)</td><td rowspan="1" colspan="1">10.4 (19.6)</td><td rowspan="1" colspan="1">17.1 (27.5)</td><td rowspan="1" colspan="1">26.4 (41.3)</td><td rowspan="1" colspan="1">&lt;0.001**</td><td rowspan="1" colspan="1">0.73</td></tr><tr><td rowspan="1" colspan="1">REM:NREM AHI ratio</td><td rowspan="1" colspan="1">1.9 (3.9)</td><td rowspan="1" colspan="1">1.4 (2.5)</td><td rowspan="1" colspan="1">1.2 (1.2)</td><td rowspan="1" colspan="1">0.002**</td><td rowspan="1" colspan="1">0.20</td></tr><tr><td rowspan="1" colspan="1">Central apnoea index (events/hr)</td><td rowspan="1" colspan="1">0.2 (0.5)</td><td rowspan="1" colspan="1">0.2 (0.5)</td><td rowspan="1" colspan="1">0.0 (0.6)</td><td rowspan="1" colspan="1">0.748</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">SpO<sub>2</sub> &lt; 90% (mins)</td><td rowspan="1" colspan="1">0.4 (2.3)</td><td rowspan="1" colspan="1">1.2 (6.0)</td><td rowspan="1" colspan="1">3.2 (12.9)</td><td rowspan="1" colspan="1">&lt;0.001**</td><td rowspan="1" colspan="1">0.53</td></tr><tr><td rowspan="1" colspan="1">ODI (events/hr)</td><td rowspan="1" colspan="1">9.1 (15.2)</td><td rowspan="1" colspan="1">14.1 (21.0)</td><td rowspan="1" colspan="1">20.0 (31.7)</td><td rowspan="1" colspan="1">&lt;0.001**</td><td rowspan="1" colspan="1">0.35</td></tr><tr><td rowspan="1" colspan="1">Awake average SpO<sub>2</sub> (%)</td><td rowspan="1" colspan="1">96.0 (2.0)</td><td rowspan="1" colspan="1">96.0 (2.0)</td><td rowspan="1" colspan="1">95.0 (2.0)</td><td rowspan="1" colspan="1">&lt;0.001**</td><td rowspan="1" colspan="1">0.12</td></tr><tr><td rowspan="1" colspan="1">Lowest SpO<sub>2</sub> (%)</td><td rowspan="1" colspan="1">86.0 (8.0)</td><td rowspan="1" colspan="1">84.5 (10.0)</td><td rowspan="1" colspan="1">83.0 (12.5)</td><td rowspan="1" colspan="1">&lt;0.001**</td><td rowspan="1" colspan="1">0.71</td></tr><tr><td rowspan="1" colspan="1">Arousal index (events/hr)</td><td rowspan="1" colspan="1">22.8 (20.1)</td><td rowspan="1" colspan="1">25.6 (21.0)</td><td rowspan="1" colspan="1">30.2 (26.5)</td><td rowspan="1" colspan="1">&lt;0.001**</td><td rowspan="1" colspan="1">0.69</td></tr><tr><td rowspan="1" colspan="1">PLM index (events/hr)</td><td rowspan="1" colspan="1">0.0 (1.0)</td><td rowspan="1" colspan="1">0.0 (4.3)</td><td rowspan="1" colspan="1">0.8 (16.5)</td><td rowspan="1" colspan="1">&lt;0.001**</td><td rowspan="1" colspan="1">0.83</td></tr></tbody></table><table-wrap-foot><fn id="tfn0005"><p><citation_analysis attribute="positive"><bold>Note</bold></citation_analysis><citation_analysis attribute="neither">: Data are presented as median (IQR). **Significant, p&lt;0.05.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
      </sec>
    </sec>
    <sec id="s0004">
      <title>Discussion</title>
      <p><citation_analysis attribute="positive">We assessed prevalence of CVD and CVD risk at time of diagnosis of OSA in a sleep clinic population. Overall, 12.2% of those with OSA reported diagnosed CVD and a further 34.7% of the population met the FRS criteria for a high 10-year CVD risk. We sought to assess whether presence of CVD and 10-year CVD risk was associated with a particular clinical presentation in symptom profile or OSA disease characteristics on polysomnography. We found that higher FRS was associated with waking too early, which occurred at least once per week in 29.5% of the low CVD risk group, compared to 48.9% of the intermediate risk group and 49.1% of the high risk group. Polysomnography data demonstrated significant associations between increasing risk of CVD and increased OSA severity, as well as a number of polysomnographic variables including oxygen desaturation indices and sleep architecture characteristics. However, none of these associations remained statistically significant after adjusting for age, sex and BMI.</citation_analysis></p>
      <p><citation_analysis attribute="positive">There was no evidence of a particular symptom profile that was associated with CVD or FRS groups. The exception was an increased proportion of participants waking too early in the higher FRS groups. This difference may have been due to differences in age and sex between these groups. However, insomnia symptoms have been linked to cardiovascular mortality in large prospective studies.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0024" ref-type="bibr">24</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0025" ref-type="bibr">25</xref></citation_analysis><citation_analysis attribute="neither"> In a recent study, comorbid insomnia and obstructive sleep apnoea, or COMISA, was associated with an increased likelihood of having cardiovascular disease at baseline.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0026" ref-type="bibr">26</xref></citation_analysis><citation_analysis attribute="positive"> Interestingly, we also found an association between high CVD risk and shorter sleep efficiency and lower sleep time; however, this was not statistically significant when adjusted for age, sex and BMI.</citation_analysis></p>
      <p><citation_analysis attribute="negative">We did not find that subjective daytime sleepiness, as measured by the ESS, differed between any of the groups. Excessive daytime sleepiness (EDS) has been associated with increased CVD morbidity and mortality.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0027" ref-type="bibr">27</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0028" ref-type="bibr">28</xref></citation_analysis><citation_analysis attribute="neither"> In recent years, latent class analyses of self-reported symptoms in large cohorts of patients with moderate-to-severe OSA have consistently identified three to five symptom subtypes,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0019" ref-type="bibr">19</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0020" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0029" ref-type="bibr">29–31</xref></citation_analysis><citation_analysis attribute="positive"> which have all included core subtypes labelled “excessively sleepy”, “disturbed sleep” and “minimally symptomatic”. The replication of these subtypes across different cohorts suggest a biological basis. The “excessively sleepy” subtype in moderate-to-severe OSA (AHI&gt;15) has been linked to increased prevalence and incidence of cardiovascular disease, including cardiovascular mortality.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0007" ref-type="bibr">7</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0031" ref-type="bibr">31</xref></citation_analysis><citation_analysis attribute="neither"> However, a recent study by Trzepizur et al</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0032" ref-type="bibr">32</xref></citation_analysis><citation_analysis attribute="negative"> did not replicate this finding in a large sleep clinic-based population; they found no association between symptom subtype and major adverse cardiac events in OSA of all severity (AHI≥5). Whilst our study was cross sectional and did not assess these recognised symptom subtypes, we also found no association between prevalent cardiovascular disease or CVD risk and sleepiness as measured by the ESS. However, there are recent data that the ESS alone may not fully capture the symptom of sleepiness.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0033" ref-type="bibr">33</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">FRS has previously been assessed in a number of sleep populations using the laboratory test-based score (including total and HDL cholesterol values). In a sleep clinic cohort with newly diagnosed OSA in Greece, AHI modestly correlated with FRS</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0034" ref-type="bibr">34</xref></citation_analysis><citation_analysis attribute="positive"> which remained significant after controlling for age and BMI. That population was restricted to an age less than 65 years and excluded patients with comorbidities placing them at high CVD risk. A Chinese study</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0035" ref-type="bibr">35</xref></citation_analysis><citation_analysis attribute="neither"> calculating FRS in those with OSA found a correlation between AHI and ODI and time below SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="positive"> 90% which was significant on a stepwise multivariate regression analysis. In a Brazilian study,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0036" ref-type="bibr">36</xref></citation_analysis><citation_analysis attribute="positive"> FRS was calculated on a randomly sampled general (non-sleep clinic based) population who then underwent polysomnography. There was an increased prevalence of OSA across FRS groups; and as with our study there was a significant correlation between most sleep variables and high FRS; however, only a sleep efficiency of less than 85% was associated with a high FRS in the adjusted analyses. Using the office-based FRS (BMI predictor instead of laboratory cholesterol values), we also identified a clear positive relationship between FRS and AHI; however, this relationship was not significant after adjusting for age, sex and BMI. The nature of the relationship between cardiovascular risk and OSA severity is a subject of ongoing debate and may be heavily influenced by confounding common risk factors, such as obesity.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0037" ref-type="bibr">37</xref></citation_analysis></p>
      <p><citation_analysis attribute="negative">We also showed non-significant correlations between CVD risk and polysomnographic measures of oxygen saturation, including ODI, time spent below SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> 90% (T90), lowest SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">, and awake average SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="negative">; such that those with higher CVD risk had a higher degree of hypoxia. Interestingly, this same association was not observed between these indices and presence of established CVD, with the exception of ODI. Nocturnal intermittent hypoxia has been specifically associated with CVD in population studies.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0008" ref-type="bibr">8</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0038" ref-type="bibr">38</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0039" ref-type="bibr">39</xref></citation_analysis><citation_analysis attribute="neither"> Hypoxic burden, determined by measuring the respiratory event-related area under the desaturation curve from a pre-event baseline,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0040" ref-type="bibr">40</xref></citation_analysis><citation_analysis attribute="neither"> has been strongly associated with CVD mortality, cardiovascular events and incident heart failure across populations.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0009" ref-type="bibr">9</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0032" ref-type="bibr">32</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0041" ref-type="bibr">41</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0042" ref-type="bibr">42</xref></citation_analysis><citation_analysis attribute="positive"> Whilst our study also reported more severe hypoxia with increased FRS, the association was not significant after adjusting for age, sex and BMI. This may be a consequence of common risk factors for both OSA and CVD, including age, male sex and obesity, which are included in the FRS calculation, making it difficult to determine the independent contribution to CVD from OSA.</citation_analysis></p>
      <p><citation_analysis attribute="negative">We showed that established CVD and high CVD risk were associated with more arousals. PLMs also increased with FRS group (but not with established CVD). This same pattern was also seen in the Brazilian sleep cohort study.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0036" ref-type="bibr">36</xref></citation_analysis><citation_analysis attribute="neither"> Significant PLMs have been identified as a polysomnographic subtype of OSA that has been linked with higher incident CVD and CVD-specific mortality risk.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0004" ref-type="bibr">4</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0043" ref-type="bibr">43</xref></citation_analysis><citation_analysis attribute="positive"> Arousals have also been shown to be independently associated with prevalent hypertension in patients with OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0044" ref-type="bibr">44</xref></citation_analysis><citation_analysis attribute="positive"> Although this finding was only suggestive in our population, it is in line with these previous findings of an association with CVD risk.</citation_analysis></p>
    </sec>
    <sec id="s0005">
      <title>Limitations</title>
      <p><citation_analysis attribute="positive">This cross-sectional study of a sleep clinic population has limitations. Recruitment to the SSB is via an opt-in process, and therefore the sample may be subject to volunteer bias and may not represent the sleep clinic in its entirety. The CVD data used in this study were collected by self-report and therefore could be subject to recall bias. Our sample size may have been too small to detect significant associations between OSA and CVD given the confounding effects of age, sex and BMI. Other variables such as medication use may also mediate associations but were unmeasured in this study. Additionally, this was an observational study. By adjusting analyses for factors already included in the calculation of FRS (namely, age, sex, and BMI), we may have underestimated the significance of the correlations between the polysomnographic variables and cardiovascular risk. Finally, this study had an AHI threshold ≥ 5, which may have underestimated correlations between cardiovascular risk and both symptoms and polysomnographic variables compared to a higher threshold of ≥ 15.</citation_analysis></p>
    </sec>
    <sec id="s0006">
      <title>Conclusions</title>
      <p><citation_analysis attribute="positive">Higher CVD risk, but not established CVD, was associated with more frequent insomnia symptoms in a multi-site sleep clinic population newly diagnosed with OSA. There were multiple variations in sleep architecture, OSA severity, oxygen desaturation, PLMs and arousals between CVD and CVD risk groups; however, these associations appeared to be due to differences in age, sex and BMI. Further research is needed to elucidate OSA phenotypic subtypes that are associated with CVD risk for the purposes of delineating personalised management strategies. The cardiovascular impact of OSA treatment, for example CPAP, in relation to such subtypes also merits exploration.</citation_analysis></p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p><citation_analysis attribute="neither">The authors acknowledge the work of all those that have contributed to the Sydney Sleep Biobank (SSB) data collection. The authors would additionally like to thank all the SSB participants for contributing their data to this effort.</citation_analysis></p>
    </ack>
    <sec id="s0007">
      <title>Sydney Sleep Biobank Investigators</title>
      <p><citation_analysis attribute="positive"><italic toggle="yes">University of Sydney -</italic></citation_analysis><citation_analysis attribute="neither"> Peter Cistulli, Philip de Chazal, Kate Sutherland, Nina Sarkissian, Yu Sun Bin, Chin Moi Chow; </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Royal North Shore Hospital</italic></citation_analysis><citation_analysis attribute="neither"> - Andrew Chan, Aimee Lowth, Jacob Graham, William Wood, Gary Cohen, Callum Bennett, Mohammad Ahmadi; </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Westmead Hospital</italic></citation_analysis><citation_analysis attribute="neither"> - John Wheatley, Kristina Kairaitis, Stephen Lambert, Rita Ginn, Tracey Burns; </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Royal Price Alfred</italic></citation_analysis><citation_analysis attribute="neither"> - Brendon Yee, Amanda Piper, Keith Wong, Kerri Melehan, Margaret Chan, David Wang, Gislaine Gauthier.</citation_analysis></p>
    </sec>
    <sec sec-type="COI-statement" id="s0008">
      <title>Disclosure</title>
      <p><citation_analysis attribute="neither">Dr Andrew Chan reports personal fees from SomnoMed Limited, outside the submitted work. Dr Amanda Piper reports personal fees from Phillips, personal fees from Up to Date, outside the submitted work. Professor Peter Cistulli holds an academic chair that was funded by ResMed; also a consultant to ResMed, with fees being paid to the University; in addition reports personal fees from Somnomed, from Signifier Medical, and from Sunrise Medical, outside the submitted work. The authors report no other conflicts of interest in this work.</citation_analysis></p>
      <p><citation_analysis attribute="neither">The abstract of this paper was presented at the Sleep Down Under Conference 2022 as a conference talk with interim findings. The abstract was published in </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Sleep Advances, Volume 3, Issue Supplement 1, October 2022</italic></citation_analysis><citation_analysis attribute="neither">: </citation_analysis><citation_analysis attribute="positive"><underline><ext-link xlink:href="https://doi.org/10.1093/sleepadvances/zpac029.011" ext-link-type="uri">https://doi.org/10.1093/sleepadvances/zpac029.011</ext-link></underline></citation_analysis><citation_analysis attribute="neither">.</citation_analysis></p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="cit0001">
        <label>1.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Benjafield</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ayas</surname>
<given-names>NT</given-names></string-name>, <string-name><surname>Eastwood</surname>
<given-names>PR</given-names></string-name>, et al. <article-title>Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis</article-title>. <source><italic toggle="yes">Lancet Respir Med</italic></source>. <year>2019</year>;<volume>7</volume>(<issue>8</issue>):<fpage>687</fpage>–<lpage>698</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S2213-2600(19)30198-5</pub-id><pub-id pub-id-type="pmid">31300334</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0002">
        <label>2.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bauters</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Rietzschel</surname>
<given-names>ER</given-names></string-name>, <string-name><surname>Hertegonne</surname>
<given-names>KB</given-names></string-name>, <string-name><surname>Chirinos</surname>
<given-names>JA</given-names></string-name>. <article-title>The link between obstructive sleep apnea and cardiovascular disease</article-title>. <source><italic toggle="yes">Curr Atheroscler Rep</italic></source>. <year>2016</year>;<volume>18</volume>(<issue>1</issue>):<fpage>1</fpage>. doi:<pub-id pub-id-type="doi">10.1007/s11883-015-0556-z</pub-id><pub-id pub-id-type="pmid">26710793</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0003">
        <label>3.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bonsignore</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Suarez Giron</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Marrone</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Castrogiovanni</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Montserrat</surname>
<given-names>JM</given-names></string-name>. <article-title>Personalised medicine in sleep respiratory disorders: focus on obstructive sleep apnoea diagnosis and treatment</article-title>. <source><italic toggle="yes">Eur Respir Rev</italic></source>. <year>2017</year>;<volume>26</volume>(<issue>146</issue>). doi:<pub-id pub-id-type="doi">10.1183/16000617.0069-2017</pub-id></mixed-citation>
      </ref>
      <ref id="cit0004">
        <label>4.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zinchuk</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Yaggi</surname>
<given-names>HK</given-names></string-name>. <article-title>Phenotypic Subtypes of OSA: a challenge and opportunity for precision medicine</article-title>. <source><italic toggle="yes">Chest</italic></source>. <year>2020</year>;<volume>157</volume>(<issue>2</issue>):<fpage>403</fpage>–<lpage>420</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chest.2019.09.002</pub-id><pub-id pub-id-type="pmid">31539538</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0005">
        <label>5.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zinchuk</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Gentry</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Concato</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Yaggi</surname>
<given-names>HK</given-names></string-name>. <article-title>Phenotypes in obstructive sleep apnea: a definition, examples and evolution of approaches</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2017</year>;<volume>35</volume>:<fpage>113</fpage>–<lpage>123</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smrv.2016.10.002</pub-id><pub-id pub-id-type="pmid">27815038</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0006">
        <label>6.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sutherland</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Yee</surname>
<given-names>BJ</given-names></string-name>, <string-name><surname>Kairaitis</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Wheatley</surname>
<given-names>J</given-names></string-name>, <string-name><surname>de Chazal</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Cistulli</surname>
<given-names>PA</given-names></string-name>. <article-title>A phenotypic approach for personalised management of obstructive sleep apnoea</article-title>. <source><italic toggle="yes">Curr Otorhinolaryngol Rep</italic></source>. <year>2021</year>;<volume>1–15</volume>:<fpage>2167</fpage>.</mixed-citation>
      </ref>
      <ref id="cit0007">
        <label>7.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Mazzotti</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Keenan</surname>
<given-names>BT</given-names></string-name>, <string-name><surname>Lim</surname>
<given-names>DC</given-names></string-name>, <string-name><surname>Gottlieb</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Pack</surname>
<given-names>AI</given-names></string-name>. <article-title>Symptom subtypes of obstructive sleep apnea predict incidence of cardiovascular outcomes</article-title>. <source><italic toggle="yes">Am J Respir Crit Care Med</italic></source>. <year>2019</year>;<volume>200</volume>(<issue>4</issue>):<fpage>493</fpage>–<lpage>506</lpage>. doi:<pub-id pub-id-type="doi">10.1164/rccm.201808-1509OC</pub-id><pub-id pub-id-type="pmid">30764637</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0008">
        <label>8.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zinchuk</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Jeon</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Koo</surname>
<given-names>BB</given-names></string-name>, et al. <article-title>Polysomnographic phenotypes and their cardiovascular implications in obstructive sleep apnoea</article-title>. <source><italic toggle="yes">Thorax</italic></source>. <year>2018</year>;<volume>73</volume>(<issue>5</issue>):<fpage>472</fpage>–<lpage>480</lpage>. doi:<pub-id pub-id-type="doi">10.1136/thoraxjnl-2017-210431</pub-id><pub-id pub-id-type="pmid">28935698</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0009">
        <label>9.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Azarbarzin</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Sands</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Stone</surname>
<given-names>KL</given-names></string-name>, et al. <article-title>The hypoxic burden of sleep apnoea predicts cardiovascular disease-related mortality: the osteoporotic fractures in men study and the sleep heart health study</article-title>. <source><italic toggle="yes">Eur Heart J</italic></source>. <year>2018</year>;<volume>3</volume>:<fpage>1</fpage>.</mixed-citation>
      </ref>
      <ref id="cit0010">
        <label>10.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Aurora</surname>
<given-names>RN</given-names></string-name>, <string-name><surname>Crainiceanu</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Gottlieb</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Punjabi</surname>
<given-names>NM</given-names></string-name>. <article-title>Obstructive sleep apnea during REM sleep and cardiovascular disease</article-title>. <source><italic toggle="yes">Am J Respir Crit Care Med</italic></source>. <year>2018</year>;<volume>197</volume>(<issue>5</issue>):<fpage>653</fpage>–<lpage>660</lpage>. doi:<pub-id pub-id-type="doi">10.1164/rccm.201706-1112OC</pub-id><pub-id pub-id-type="pmid">29112823</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0011">
        <label>11.</label>
        <mixed-citation publication-type="journal"><string-name><surname>D’Agostino</surname>
<given-names>RB</given-names></string-name>, <string-name><surname>Vasan</surname>
<given-names>RS</given-names></string-name>, <string-name><surname>Pencina</surname>
<given-names>MJ</given-names></string-name>, et al. <article-title>General cardiovascular risk profile for use in primary care: the Framingham heart study</article-title>. <source><italic toggle="yes">Circulation</italic></source>. <year>2008</year>;<volume>117</volume>(<issue>6</issue>):<fpage>743</fpage>–<lpage>753</lpage>. doi:<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.107.699579</pub-id><pub-id pub-id-type="pmid">18212285</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0012">
        <label>12.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sutherland</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Sarkissian</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Amis</surname>
<given-names>TC</given-names></string-name>, et al. <article-title>Sydney Sleep Biobank (SSB): development of a research resource</article-title>. <source><italic toggle="yes">In Journal of Sleep Research</italic></source>. <year>2019</year>;<volume>28</volume>:<fpage>3</fpage>.</mixed-citation>
      </ref>
      <ref id="cit0013">
        <label>13.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Johns</surname>
<given-names>MW</given-names></string-name>. <article-title>A new method for measuring daytime sleepiness: the Epworth sleepiness scale</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>1991</year>;<volume>14</volume>(<issue>6</issue>):<fpage>540</fpage>–<lpage>545</lpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/14.6.540</pub-id><pub-id pub-id-type="pmid">1798888</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0014">
        <label>14.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chasens</surname>
<given-names>ER</given-names></string-name>, <string-name><surname>Ratcliffe</surname>
<given-names>SJ</given-names></string-name>, <string-name><surname>Weaver</surname>
<given-names>TE</given-names></string-name>. <article-title>Development of the FOSQ-10: a short version of the functional outcomes of sleep questionnaire</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2009</year>;<volume>32</volume>(<issue>7</issue>):<fpage>915</fpage>–<lpage>919</lpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/32.7.915</pub-id><pub-id pub-id-type="pmid">19639754</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0015">
        <label>15.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Buysse</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Reynolds</surname>
<given-names>CF</given-names></string-name>, <string-name><surname>Monk</surname>
<given-names>TH</given-names></string-name>, <string-name><surname>Berman</surname>
<given-names>SR</given-names></string-name>, <string-name><surname>Kupfer</surname>
<given-names>DJ</given-names></string-name>. <article-title>The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research</article-title>. <source><italic toggle="yes">Psychiatry Res</italic></source>. <year>1989</year>;<volume>28</volume>(<issue>2</issue>):<fpage>193</fpage>–<lpage>213</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0165-1781(89)90047-4</pub-id><pub-id pub-id-type="pmid">2748771</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0016">
        <label>16.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Magalang</surname>
<given-names>UJ</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>NH</given-names></string-name>, <string-name><surname>Cistulli</surname>
<given-names>PA</given-names></string-name>, et al. <article-title>Agreement in the scoring of respiratory events and sleep among international sleep centers</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2013</year>;<volume>36</volume>(<issue>4</issue>):<fpage>591</fpage>–<lpage>596</lpage>. doi:<pub-id pub-id-type="doi">10.5665/sleep.2552</pub-id><pub-id pub-id-type="pmid">23565005</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0017">
        <label>17.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bastien</surname>
<given-names>CH</given-names></string-name>, <string-name><surname>Vallieres</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Morin</surname>
<given-names>CM</given-names></string-name>. <article-title>Validation of the insomnia severity index as an outcome measure for insomnia research</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2001</year>;<volume>2</volume>(<issue>4</issue>):<fpage>297</fpage>–<lpage>307</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1389-9457(00)00065-4</pub-id><pub-id pub-id-type="pmid">11438246</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0018">
        <label>18.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Netzer</surname>
<given-names>NC</given-names></string-name>, <string-name><surname>Stoohs</surname>
<given-names>RA</given-names></string-name>, <string-name><surname>Netzer</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Clark</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Strohl</surname>
<given-names>KP</given-names></string-name>. <article-title>Using the berlin questionnaire to identify patients at risk for the sleep apnea syndrome</article-title>. <source><italic toggle="yes">Ann Intern Med</italic></source>. <year>1999</year>;<volume>131</volume>(<issue>7</issue>):<fpage>485</fpage>. doi:<pub-id pub-id-type="doi">10.7326/0003-4819-131-7-199910050-00002</pub-id><pub-id pub-id-type="pmid">10507956</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0019">
        <label>19.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Keenan</surname>
<given-names>BT</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Singh</surname>
<given-names>B</given-names></string-name>, et al. <article-title>Recognizable clinical subtypes of obstructive sleep apnea across international sleep centers: a cluster analysis</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2018</year>;<volume>41</volume>(<issue>3</issue>). doi:<pub-id pub-id-type="doi">10.1093/sleep/zsx214</pub-id></mixed-citation>
      </ref>
      <ref id="cit0020">
        <label>20.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ye</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Pien</surname>
<given-names>GW</given-names></string-name>, <string-name><surname>Ratcliffe</surname>
<given-names>SJ</given-names></string-name>, et al. <article-title>The different clinical faces of obstructive sleep apnoea: a cluster analysis</article-title>. <source><italic toggle="yes">Eur Respir J</italic></source>. <year>2014</year>;<volume>44</volume>(<issue>6</issue>):<fpage>1600</fpage>–<lpage>1607</lpage>. doi:<pub-id pub-id-type="doi">10.1183/09031936.00032314</pub-id><pub-id pub-id-type="pmid">25186268</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0021">
        <label>21.</label>
        <mixed-citation publication-type="book"><string-name><surname>Berry</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Quan</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Abreu</surname>
<given-names>A</given-names></string-name>, et al. <source><italic toggle="yes">The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications</italic></source>. Vol. <volume>2</volume>. <publisher-loc>Darien, Illinois</publisher-loc>: <publisher-name>American Academy of Sleep Medicine</publisher-name>; <year>2020</year>.</mixed-citation>
      </ref>
      <ref id="cit0022">
        <label>22.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Jorgensen</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Downey</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Goldin</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Melehan</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Rochford</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Ruehland</surname>
<given-names>W</given-names></string-name>. <article-title>An Australasian commentary on the AASM manual for the scoring of sleep and associated events</article-title>. <source><italic toggle="yes">Sleep Biol Rhythms</italic></source>. <year>2020</year>;<volume>18</volume>(<issue>3</issue>):<fpage>163</fpage>–<lpage>185</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s41105-020-00259-9</pub-id></mixed-citation>
      </ref>
      <ref id="cit0023">
        <label>23.</label>
        <mixed-citation publication-type="webpage"><collab>Jamovi</collab>. <article-title>The Jamovi Project</article-title>; <year>2022</year>. <comment>Available from</comment>: <ext-link xlink:href="https://www.jamovi.org" ext-link-type="uri">https://www.jamovi.org</ext-link>. <date-in-citation>Accessed <month>May</month>
<day>1</day>, 2024</date-in-citation>.</mixed-citation>
      </ref>
      <ref id="cit0024">
        <label>24.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sofi</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Cesari</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Casini</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Macchi</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Abbate</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Gensini</surname>
<given-names>GF</given-names></string-name>. <article-title>Insomnia and risk of cardiovascular disease: a meta-analysis</article-title>. <source><italic toggle="yes">Eur J Prev Cardiol</italic></source>. <year>2014</year>;<volume>21</volume>(<issue>1</issue>):<fpage>57</fpage>–<lpage>64</lpage>. doi:<pub-id pub-id-type="doi">10.1177/2047487312460020</pub-id><pub-id pub-id-type="pmid">22942213</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0025">
        <label>25.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bertisch</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Pollock</surname>
<given-names>BD</given-names></string-name>, <string-name><surname>Mittleman</surname>
<given-names>MA</given-names></string-name>, et al. <article-title>Insomnia with objective short sleep duration and risk of incident cardiovascular disease and all-cause mortality</article-title>. <source><italic toggle="yes">Sleep Heart Health Study Sleep</italic></source>. <year>2018</year>;<volume>41</volume>:<fpage>6</fpage>.</mixed-citation>
      </ref>
      <ref id="cit0026">
        <label>26.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lechat</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Appleton</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Melaku</surname>
<given-names>YA</given-names></string-name>, et al. <article-title>The association of co‐morbid insomnia and sleep apnea with prevalent cardiovascular disease and incident cardiovascular events</article-title>. <source><italic toggle="yes">J Sleep Res</italic></source>. <year>2022</year>;<volume>31</volume>(<issue>5</issue>). doi:<pub-id pub-id-type="doi">10.1111/jsr.13563</pub-id></mixed-citation>
      </ref>
      <ref id="cit0027">
        <label>27.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Empana</surname>
<given-names>JP</given-names></string-name>, <string-name><surname>Dauvilliers</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Dartigues</surname>
<given-names>JF</given-names></string-name>, et al. <article-title>Excessive daytime sleepiness is an independent risk indicator for cardiovascular mortality in community-dwelling elderly: the three city study</article-title>. <source><italic toggle="yes">Stroke</italic></source>. <year>2009</year>;<volume>40</volume>(<issue>4</issue>):<fpage>1219</fpage>–<lpage>1224</lpage>. doi:<pub-id pub-id-type="doi">10.1161/STROKEAHA.108.530824</pub-id><pub-id pub-id-type="pmid">19246707</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0028">
        <label>28.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gooneratne</surname>
<given-names>NS</given-names></string-name>, <string-name><surname>Richards</surname>
<given-names>KC</given-names></string-name>, <string-name><surname>Joffe</surname>
<given-names>M</given-names></string-name>, et al. <article-title><italic toggle="yes">Sleep</italic> disordered breathing with excessive daytime sleepiness is a risk factor for mortality in older adults</article-title>. <italic toggle="yes">Sleep</italic>. <year>2011</year>;<volume>34</volume>(<issue>4</issue>):<fpage>435</fpage>–<lpage>442</lpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/34.4.435</pub-id></mixed-citation>
      </ref>
      <ref id="cit0029">
        <label>29.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kim</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Keenan</surname>
<given-names>BT</given-names></string-name>, <string-name><surname>Lim</surname>
<given-names>DC</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>SK</given-names></string-name>, <string-name><surname>Pack</surname>
<given-names>AI</given-names></string-name>, <string-name><surname>Shin</surname>
<given-names>C</given-names></string-name>. <article-title>Symptom-based subgroups of Koreans with obstructive sleep apnea</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2018</year>;<volume>14</volume>(<issue>3</issue>):<fpage>437</fpage>–<lpage>443</lpage>. doi:<pub-id pub-id-type="doi">10.5664/jcsm.6994</pub-id><pub-id pub-id-type="pmid">29510793</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0030">
        <label>30.</label>
        <mixed-citation publication-type="journal"><string-name><surname>González</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Tarraf</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Wallace</surname>
<given-names>DM</given-names></string-name>, et al. <article-title>Phenotypes of obstructive sleep apnea in the Hispanic Community Health Study/Study of Latinos</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2021</year>;<volume>44</volume>(<issue>12</issue>). doi:<pub-id pub-id-type="doi">10.1093/sleep/zsab181</pub-id></mixed-citation>
      </ref>
      <ref id="cit0031">
        <label>31.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Labarca</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Dreyse</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Salas</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Letelier</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Jorquera</surname>
<given-names>J</given-names></string-name>. <article-title>A validation study of four different cluster analyses of OSA and the incidence of cardiovascular mortality in a Hispanic population</article-title>. <source><italic toggle="yes">Chest</italic></source>. <year>2021</year>;<volume>160</volume>(<issue>6</issue>):<fpage>2266</fpage>–<lpage>2274</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chest.2021.06.047</pub-id><pub-id pub-id-type="pmid">34217682</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0032">
        <label>32.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Trzepizur</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Blanchard</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ganem</surname>
<given-names>T</given-names></string-name>, et al. <article-title>Sleep apnea–specific hypoxic burden, symptom subtypes, and risk of cardiovascular events and all-cause mortality</article-title>. <source><italic toggle="yes">Am J Respir Crit Care Med</italic></source>. <year>2022</year>;<volume>205</volume>(<issue>1</issue>):<fpage>108</fpage>–<lpage>117</lpage>. doi:<pub-id pub-id-type="doi">10.1164/rccm.202105-1274OC</pub-id><pub-id pub-id-type="pmid">34648724</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0033">
        <label>33.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Thorarinsdottir</surname>
<given-names>EH</given-names></string-name>, <string-name><surname>Gislason</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Pack</surname>
<given-names>AI</given-names></string-name>, et al. <article-title>Evaluation of excessive daytime sleepiness in obstructive sleep apnea across international sleep centers</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2023</year>;<volume>46</volume>(<issue>8</issue>). doi:<pub-id pub-id-type="doi">10.1093/sleep/zsac271</pub-id></mixed-citation>
      </ref>
      <ref id="cit0034">
        <label>34.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Archontogeorgis</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Voulgaris</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Nena</surname>
<given-names>E</given-names></string-name>, et al. <article-title>Cardiovascular risk assessment in a cohort of newly diagnosed patients with obstructive sleep apnea syndrome</article-title>. <source><italic toggle="yes">Cardiol Res Pract</italic></source>. <year>2018</year>;<volume>2018</volume>:<fpage>6572785</fpage>. doi:<pub-id pub-id-type="doi">10.1155/2018/6572785</pub-id><pub-id pub-id-type="pmid">29707392</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0035">
        <label>35.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>XF</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>QY</given-names></string-name>, <string-name><surname>Wan</surname>
<given-names>HY</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>M</given-names></string-name>. <article-title>The influencing factors of Framingham cardiovascular risk score in patients with obstructive sleep apnea-hypopnea syndrome</article-title>. <source><italic toggle="yes">Zhonghua Yi Xue Za Zhi</italic></source>. <year>2007</year>;<volume>87</volume>(<issue>31</issue>):<fpage>2176</fpage>–<lpage>2180</lpage>.<pub-id pub-id-type="pmid">18001525</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0036">
        <label>36.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Cintra</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Bittencourt</surname>
<given-names>LR</given-names></string-name>, <string-name><surname>Santos-Silva</surname>
<given-names>R</given-names></string-name>, et al. <article-title>The association between the Framingham risk score and sleep: a Sao Paulo epidemiological sleep study</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2012</year>;<volume>13</volume>(<issue>6</issue>):<fpage>577</fpage>–<lpage>582</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2011.12.016</pub-id><pub-id pub-id-type="pmid">22516609</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0037">
        <label>37.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Carratù</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Di Ciaula</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Dragonieri</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Relationships between obstructive sleep apnea syndrome and cardiovascular risk in a naïve population of southern Italy</article-title>. <source><italic toggle="yes">Int J Clin Pract</italic></source>. <year>2021</year>;<volume>75</volume>(<issue>12</issue>). doi:<pub-id pub-id-type="doi">10.1111/ijcp.14952</pub-id></mixed-citation>
      </ref>
      <ref id="cit0038">
        <label>38.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Punjabi</surname>
<given-names>NM</given-names></string-name>, <string-name><surname>Caffo</surname>
<given-names>BS</given-names></string-name>, <string-name><surname>Goodwin</surname>
<given-names>JL</given-names></string-name>, et al. <article-title>Sleep-disordered breathing and mortality: a prospective cohort study</article-title>. <source><italic toggle="yes">PLoS Med</italic></source>. <year>2009</year>;<volume>6</volume>(<issue>8</issue>):<fpage>e1000132</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pmed.1000132</pub-id><pub-id pub-id-type="pmid">19688045</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0039">
        <label>39.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Stone</surname>
<given-names>KL</given-names></string-name>, <string-name><surname>Blackwell</surname>
<given-names>TL</given-names></string-name>, <string-name><surname>Ancoli-Israel</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Sleep disordered breathing and risk of stroke in older community-dwelling men</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2016</year>;<volume>39</volume>(<issue>3</issue>):<fpage>531</fpage>–<lpage>540</lpage>. doi:<pub-id pub-id-type="doi">10.5665/sleep.5520</pub-id><pub-id pub-id-type="pmid">26943468</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0040">
        <label>40.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Azarbarzin</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Sands</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Taranto-Montemurro</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Redline</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Wellman</surname>
<given-names>A</given-names></string-name>. <article-title>Hypoxic burden captures sleep apnoea-specific nocturnal hypoxaemia</article-title>. <source><italic toggle="yes">Eur Heart J</italic></source>. <year>2019</year>;<volume>40</volume>(<issue>35</issue>):<fpage>2989</fpage>–<lpage>2990</lpage>. doi:<pub-id pub-id-type="doi">10.1093/eurheartj/ehz274</pub-id><pub-id pub-id-type="pmid">31071210</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0041">
        <label>41.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Azarbarzin</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Sands</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Taranto-Montemurro</surname>
<given-names>L</given-names></string-name>, et al. <article-title>The sleep apnea-specific hypoxic burden predicts incident heart failure</article-title>. <source><italic toggle="yes">Chest</italic></source>. <year>2020</year>;<volume>158</volume>(<issue>2</issue>):<fpage>739</fpage>–<lpage>750</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chest.2020.03.053</pub-id><pub-id pub-id-type="pmid">32298733</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0042">
        <label>42.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Labarca</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Jorquera</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Dreyse</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Salas</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Letelier</surname>
<given-names>F</given-names></string-name>. <article-title>Hypoxemic features of obstructive sleep apnea and the risk of mortality: a cluster analysis</article-title>. <source><italic toggle="yes">Sleep Breathing</italic></source>. <year>2021</year>;<volume>25</volume>(<issue>1</issue>):<fpage>95</fpage>–<lpage>103</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11325-020-02064-7</pub-id><pub-id pub-id-type="pmid">32232718</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0043">
        <label>43.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kim</surname>
<given-names>JW</given-names></string-name>, <string-name><surname>Won</surname>
<given-names>TB</given-names></string-name>, <string-name><surname>Rhee</surname>
<given-names>CS</given-names></string-name>, <string-name><surname>Park</surname>
<given-names>YM</given-names></string-name>, <string-name><surname>Yoon</surname>
<given-names>IY</given-names></string-name>, <string-name><surname>Cho</surname>
<given-names>SW</given-names></string-name>. <article-title>Polysomnographic phenotyping of obstructive sleep apnea and its implications in mortality in Korea</article-title>. <source><italic toggle="yes">Sci Rep</italic></source>. <year>2020</year>;<volume>10</volume>(<issue>1</issue>):<fpage>13207</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-020-70039-5</pub-id><pub-id pub-id-type="pmid">32764677</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0044">
        <label>44.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ren</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Somers</surname>
<given-names>VK</given-names></string-name>, <string-name><surname>Covassin</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Tang</surname>
<given-names>X</given-names></string-name>. <article-title>Association between arousals during sleep and hypertension among patients with obstructive sleep apnea</article-title>. <source><italic toggle="yes">J Am Heart Assoc</italic></source>. <year>2022</year>;<volume>11</volume>(<issue>1</issue>). doi:<pub-id pub-id-type="doi">10.1161/JAHA.121.022141</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
